Usefulness of serum carcinoembryonic antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: a prospective cohort study.
Arrieta, Oscar
Usefulness of serum carcinoembryonic antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: a prospective cohort study. [electronic resource] - BMC cancer May 2013 - 254 p. digital
Publication Type: Journal Article
1471-2407
10.1186/1471-2407-13-254 doi
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor
Carcinoembryonic Antigen--blood
Carcinoma, Non-Small-Cell Lung--blood
Disease Progression
Female
Humans
Lung Neoplasms--blood
Male
Middle Aged
Neoplasm Staging
Prognosis
Prospective Studies
ROC Curve
Risk Factors
Treatment Outcome
Usefulness of serum carcinoembryonic antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: a prospective cohort study. [electronic resource] - BMC cancer May 2013 - 254 p. digital
Publication Type: Journal Article
1471-2407
10.1186/1471-2407-13-254 doi
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor
Carcinoembryonic Antigen--blood
Carcinoma, Non-Small-Cell Lung--blood
Disease Progression
Female
Humans
Lung Neoplasms--blood
Male
Middle Aged
Neoplasm Staging
Prognosis
Prospective Studies
ROC Curve
Risk Factors
Treatment Outcome